Cargando…
DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report
Hypertension and type 2 diabetes mellitus (DM) are among the main risk factors for the development of cardiovascular disease. Pharmacotherapy for DM should not only improve blood glucose control, but also provide beneficial glucose-independent cardiovascular effects. The central systolic blood press...
Autores principales: | Cosenso-Martin, Luciana Neves, Giollo-Junior, Luiz Tadeu, Vilela-Martin, José Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504643/ https://www.ncbi.nlm.nih.gov/pubmed/26166078 http://dx.doi.org/10.1097/MD.0000000000001068 |
Ejemplares similares
-
Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
por: Fernandes, Leticia Aparecida Barufi, et al.
Publicado: (2016) -
Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2015) -
Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
por: Vaz-de-Melo, Renan Oliveira, et al.
Publicado: (2014) -
Association of central blood pressure and cardiovascular diseases in diabetic patients with hypertension
por: Yang, Lei, et al.
Publicado: (2017) -
Central hemodynamics and the discrepancy between central blood pressure and brachial blood pressure
por: Park, Jin-Sun, et al.
Publicado: (2022)